{"id":108002,"date":"2014-02-12T13:48:03","date_gmt":"2014-02-12T18:48:03","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/medicine-gets-up-close-and-personal.php"},"modified":"2014-02-12T13:48:03","modified_gmt":"2014-02-12T18:48:03","slug":"medicine-gets-up-close-and-personal","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/medicine-gets-up-close-and-personal.php","title":{"rendered":"Medicine gets up close and personal"},"content":{"rendered":"<p><p>        Source: Institute for Systems Biology      <\/p>\n<p>    Leroy Hood, president of the Institute for Systems Biology    (ISB) in Seattle, Washington, likes to talk about what he calls    P4 medicine: health care that is predictive, preventive,    personalized and participatory. Medicine today is a string of    infrequent interventions prompted mainly by symptoms of    illness. Hood argues instead for continuous management of    health, making full use of whole-genome sequencing and    biomarkers to correct disease before it gains a    foothold.  <\/p>\n<p>    In March, Hood will embark on the first big test of his ideas:    a nine-month pilot study, dubbed the Hundred Person Wellness    Project, in which 100 healthy individuals will be intensively    monitored (see An examined life), offered    regular feedback and counselled on lifestyle changes such as    shifts in their dietary or sleep habits. The effects of these    behavioural changes on their health will, in turn, be tracked    using a battery of diagnostic tests.  <\/p>\n<p>    The study violates many rules of trial design: it dispenses    with blinding and randomization, and will not even have a    control group. But Hood is confident in its power to disrupt    the conventional practice of medicine. We hope to develop a    whole series of stories about how actionable opportunities have    changed the wellness of individuals, or have made them aware of    how they can avoid disease, he says.  <\/p>\n<p>    If the pilot study works as hoped, it will expand in several    phases until it encompasses 100,000 subjects monitored over 25    years. The ISB is paying for the first hundred people through    private donations and has budgeted around US$10,000 per person.    Hood expects those costs to drop drastically in a larger study,    thanks to economies of scale and rapidly evolving diagnostic    technologies. But he acknowledges the challenge of securing the    hundreds of millions of dollars that a generation-long trial    would require.  <\/p>\n<p>    Even in its pilot phase, the project is unusually thorough. The    ISB will sequence the whole genome of each participant at the    outset. And in later phases, Hood says, the study team will    also examine epigenetics: methylation and other modifications    to DNA that can reflect environmental exposures. But that is    just the tip of the data-collection iceberg.  <\/p>\n<p>        Institute for Systems Biology      <\/p>\n<p>        Leroy Hood: We hope to develop a whole series of stories        about how actionable opportunities have changed the        wellness of individuals.      <\/p>\n<p>    Participants will be asked to wear digital devices that will    continuously record their physical activity, heart rate and    sleep patterns; subjects will periodically upload those data to    the institutes systems. Every three months, researchers will    gather samples of participants blood, urine, saliva and stool.    They will measure five biochemicals in saliva and urine, and    sequence the stool samples to track the ecology of major    microbial species in the gut. Blood-chemistry screens will    extend well beyond the usual tests for cholesterol and glucose    to include 20less-commonly monitored variables, such as    C-reactive protein  which signals inflammation at high levels.    Hoods teams will also monitor about 100 organ-specific    proteins that, he says, are sensitive markers for transitions    from health to disease in mouse and cell models.  <\/p>\n<p>    The point of the study  and of P4 medicine in general  is to    detect those transitions and respond to them before symptoms    appear. To that end, participants (mostly residents of the    Seattle area, invited through social media) will have full    access to their personal cloud of data points. Some will have    enough scientific training to dive into the literature and    interpret their data themselves. But Hood expects most to rely    on ISB-provided wellness coaches and their own physicians to    interpret the results and recommend medical treatment or    changes in diet or behaviour.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See original here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.nature.com\/doifinder\/10.1038\/506144a\" title=\"Medicine gets up close and personal\">Medicine gets up close and personal<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Source: Institute for Systems Biology Leroy Hood, president of the Institute for Systems Biology (ISB) in Seattle, Washington, likes to talk about what he calls P4 medicine: health care that is predictive, preventive, personalized and participatory. Medicine today is a string of infrequent interventions prompted mainly by symptoms of illness.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/medicine-gets-up-close-and-personal.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-108002","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/108002"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=108002"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/108002\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=108002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=108002"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=108002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}